Spontaneous development of hepatocellular carcinomas in the FLS mice with hereditary fatty liver

Cancer Letters

Volumn 196, Issue 1, 2003, Pages 43-48

  Soga, Masahiko ^a   Kishimoto, Yoshio ^a   Kawamura, Yoshihiro ^a   Inagaki, Shuichiro ^a   Makino, Susumu ^a   Saibara, Toshiji ^b  

^a SHIONOGI AND CO LTD   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Fatty liver; FLS mouse; Hepatocellular carcinoma; Steatohepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; FATTY LIVER; FEMALE; FOAM CELL; GENETIC DISORDER; HISTOLOGY; HISTOPATHOLOGY; INCIDENCE; INFLAMMATION; LIVER CELL CARCINOMA; LIVER INJURY; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; OBSERVATION; PRIORITY JOURNAL;

ANIMALIA;

EID: 0038645375     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00213-1     Document Type: Article

References (20)

1. Soga M., Kishimoto Y., Kawaguchi J., Nakai Y., Kawamura Y., Inagaki S., et al. The FLS mouse: a new inbred strain with spontaneous fatty liver. Lab. Anim. Sci. 49:1999;269-275.
2. Guidelines for animal experimentation. Exp. Anim. 36:1987;285-288.
3. Frith C.H., Ward J.M. A morphologic classification of proliferative and neoplastic hepatic lesions in mice. J. Environ. Pathol. Toxcol. 3:1979;329-351.
4. Lee G.-H., Drinkwater N.R. Hepatocarcinogenesis in BXH recombinant inbred strains of mice: analysis of diverse phenotypic effects of the hepatocarcinogen sensitivity loci. Mol. Carcinog. 14:1995;190-197.
5. Chiaverotti T., Carabeo R., Drinkwater N.R. Genetic and hormonal regulation of murine hepatocarcinogenesis. Hiai H., Hino O. Animal Models of Cancer Predisposition Syndromes. 1999;131-142 Krager, Basel.
6. Parkin D.M., Pisani P., Ferlay J. Esimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer. 54:1993;594-606.
7. Hailey J.R., Haseman J.K., Bucher J.R., Radovsky A.E., Malarkey D.E., Miller R.T., et al. Impact of Helicobacter hepaticus infection in B6C3F1 mice from twelve National Toxicology Program two-year carcinogenesis studies. Toxicol. Pathol. 26:1998;602-611.
8. Wiseman H., Halliwell B. Damage to DNA by reactive oxigen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 313:1996;17-29.
9. McCullough A.J. Update on nonalcoholic fatty liver disease. J. Clin. Gastroenterol. 34:2002;255-262.
10. James O.F., Day C.P. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J. Hepatol. 29:1998;495-501.
11. Zen Y., Katayanagi K., Tsuneyama K., Harada K., Araki I., Nakanuma Y. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. Pathol. Int. 51:2001;127-131.
12. Bugianesi E., Leone N., Vanni E., Marchesini G., Brunello F., Carucci P., et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 123:2002;134-140.
13. Shimada M., Hashimoto E., Taniai M., Hasegawa K., Okuda H., Hayashi N., et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J. Hepatol. 37:2002;154-160.
14. Heston W., Vlhakis G. Genetic obesity and neoplasia. J. Natl. Cancer Inst. (Bethesda). 29:1962;197-209.
15. Fan C.-Y., Pan J., Usuda N., Yeldandi A.V., Rao M.S., Reddy J.K. Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase: implications for peroxisome proliferator-activated receptor α natural ligand metabolism. J. Biol. Chem. 273:1998;15639-15645.
16. Nemoto Y., Toda K., Ono M., Fujikawa-Adachi K., Saibara T., Onishi S., et al. Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J Clin. Invest. 105:2000;1819-1825.
17. Reue K., Xu P., Wang X.P., Slavin B.G. Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene. J Lipid Res. 41:2000;1067-1076.
18. Yokogawa K., Yonekawa M., Tamai I., Ohashi R., Tatsumi Y., Higashi Y., et al. Loss of wild-type carrier-mediated L-carnitine transport activity in hepatocytes of juvenile visceral steatosis mice. Hepatology. 30:1999;997-1001.
19. Kutami R., Nakashima Y., Nakashima O., Shiota K., Kojiro M. Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J. Hepatol. 33:2000;282-289.
20. Moriya K., Fujie H., Shintani Y., Yotsuyanagi H., Tsutsumi T., Ishibashi K., et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 4:1998;1065-1067.